Zee Laboratories Limited

Zee Laboratories Limited - pharma in Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U74899DL1994PLC061704 Incorporated 23 September 1994 ROC Delhi HQ Delhi, Delhi, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹463.57 Cr
▲ 10.00% YoY
EBITDA · FY 2024
*****
▲ 39.00% YoY
Net profit · FY 2024
*****
▲ 42.00% YoY
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹10.09 Cr
Issued & subscribed
Open charges
None
Satisfied ₹8.95 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
417
Latest available

About Zee Laboratories Limited

Data last updated: 27 December 2025

Zee Laboratories Limited is a public limited company based in Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 September 1994, the company has been in operation for over 32 years.

Registered with ROC Delhi under CIN U74899DL1994PLC061704.

Capital: an authorised share capital of ₹13 Cr and a paid-up capital of ₹10.09 Cr. Formerly known as Zee Herbal Laboratories Private Limited and Zee Herbal Laboratories Ltd. It is led by directors including Deepak Bambha and Aarzoo Sharma.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 913 D – Mall Netaji Subhash Place Pitampura, Delhi, Delhi, India – 110034.

As per the financials filed for FY 2024, the company reported a revenue of ₹463.57 Cr, a growth of 10% compared to the previous year.

The company has a workforce of approximately 417 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Zee Healthcare. As per MCA filings, the company has satisfied charges of ₹8.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zeelab.co.in.

Company Details of Zee Laboratories Limited
CIN U74899DL1994PLC061704
Registration Number 061704
Incorporation Date 23 September 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Rajeev Mukul Managing Director Sat Pal Singh Cfo Deepak Bambha Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    zeelab.co.in
  • Social Media
  • Registered Address
    913 D – Mall Netaji Subhash Place Pitampura, Delhi, Delhi, India – 110034
  • Industry
    Pharma, Drug Formulation & Development
Company report
Zee Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Zee Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Zee Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Zee Laboratories Limited

Zee Laboratories Limited has undergone 2 name changes throughout its history. The company was previously known as Zee Herbal Laboratories Private Limited, and Zee Herbal Laboratories Ltd. The current legal name is Zee Laboratories Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Zee Laboratories Limited Current
Zee Herbal Laboratories Private Limited Previous
Zee Herbal Laboratories Ltd Previous

Associated Brands with Zee Laboratories Limited

Zee Laboratories Limited operates one associated brand: Zee Healthcare. These brands represent Zee Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Zee Healthcare
Potato farming, grain marketing, and equipment services in Maine. zeehealthcare.in

Business Activity of Zee Laboratories Limited

Zee Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Zee Laboratories Limited

Zee Laboratories Limited is audited by Vipin Kumar Mool Chand & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Vipin Kumar Mool Chand & Co. blur-value blur-value blur-value

Board of Directors of Zee Laboratories Limited

Zee Laboratories Limited is currently managed by 13 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Deepak Bambha
Also directs: Adkin Bioceuticals Private Limited, Medibruk Pharma Private Limited
Director 29 Jul 2019 6 Years 11 Months Current
Aarzoo Sharma Director 29 Jul 2023 2 Years 11 Months Current
Harish Chandra Pathak Additional Director - Current
Dhananjay Kumar Director 19 Nov 2020 5 Years 7 Months Current
Anil Mehta
Also directs: Lanark Laboratories Pvt Ltd, Antek Drugs Private Limited
Director 29 Jul 2019 6 Years 11 Months Current
Ramandeep
Also directs: Klokter Life Sciences Private Limited
Additional Director 12 Mar 2025 1 Years 3 Months Current
Showing 6 of 13 current directors. View all directors

Financials of Zee Laboratories Limited FY 2024 filings available

Zee Laboratories Limited reported revenue of ₹463.57 Cr (up 10% YoY) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹463.57 Cr ▲ 10%
Profit
***** ▲ 42%
EBITDA
***** ▲ 39%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Zee Laboratories Limited

As of FY 2024, Zee Laboratories Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Group Structure of Zee Laboratories Limited

Zee Laboratories Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Zee Laboratories Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Asian Reclamation Private Limited U25190DL1997PTC088697
**.**%

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Zee Laboratories Limited

Open charges
₹0
Satisfied charges
₹8.95 Cr
Breakdown by lending institutions
Icici Bank Limited₹4.95 Cr
State Bank of India₹4.00 Cr
Latest charge details
DateLenderAmountStatus
29 Jan 2015 Icici Bank Limited ₹4.95 Cr Satisfied
25 Feb 2010 State Bank of India ₹4 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Zee Laboratories Limited

Zee Laboratories Limited has a workforce of 417 employees as of Apr 14, 2025.

Employee count
417
Active EPFO establishments
3
Employee growth
-19.34%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Zee Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Zee Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Zee Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Zee Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Zee Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Zee Laboratories Limited

MSME Payment Delays by Zee Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Zee Laboratories Limited

Subsidiaries & Group Companies of Zee Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Zee Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Zee Laboratories Limited

MCA Filings & Documents of Zee Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Zee Laboratories Limited

Directors
11 Dec 2025
Virender Anand was appointed as a Company Secretary on 11 Dec 2025 & has been associated with this company since 7 months.
Directors
28 Nov 2025
Gurjeet Kaur was appointed as a Additional Director on 28 Nov 2025 & has been associated with this company since 7 months 13 days.
Directors
12 Mar 2025
Ramandeep was appointed as a Additional Director on 12 Mar 2025 & has been associated with this company since 1 year 4 months.
Directors
05 Mar 2025
Dikshika Kamboj was appointed as a Additional Director on 05 Mar 2025 & has been associated with this company since 1 year 4 months.
Activity
30 Sep 2024
Zee Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Directors
01 Sep 2024
Praveen Kumar Mishra was appointed as a Director on 01 Sep 2024 & has been associated with this company since 1 year 10 months.

Frequently Asked Questions about Zee Laboratories Limited

Zee Laboratories Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 23 September 1994 (32+ years old) and is registered under CIN U74899DL1994PLC061704. The company has 417 employees.

Zee Laboratories Limited reported revenue of ₹463.57 Cr for FY 2024 (up 10.00% YoY).

The current directors of Zee Laboratories Limited are:

The primary industry of Zee Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Zee Laboratories Limited can be reached at the registered office: 913 D – Mall Netaji Subhash Place Pitampura, Delhi, Delhi, India – 110034, or through the website zeelab.co.in.

The authorised capital is ₹13 Cr, and the paid-up capital is ₹10.09 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available